Nucleic Acid Therapeutics Initiative
  • Organisation
  • Science
  • Accelerator
    • Funding Platform
    • Funding Opportunities
    • Portfolio
  • Careers
  • News & Events

Agilent and Singapore’s NATi Partner to Advance Lipid-Conjugated Oligonucleotide Research

20 May 2026 Read Full Article ↗
← Previous Article SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore
← Back to News
Email
LinkedIn
Nucleic Acid Therapeutics Initiative (NATi)
31 Biopolis Way, Nanos #09-01, Singapore 138669
© 2026 Nucleic Acid Therapeutics Initiative | Privacy Policy | Terms and Conditions
Nucleic Acid Therapeutics Initiative
Join OurMailing List